290 related articles for article (PubMed ID: 30402908)
21. Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective.
Conte M; Franceschi C; Sandri M; Salvioli S
Trends Endocrinol Metab; 2016 Dec; 27(12):893-903. PubMed ID: 27659144
[TBL] [Abstract][Full Text] [Related]
22. Obstructive Sleep Apnea Syndrome and Metabolic Diseases.
Li M; Li X; Lu Y
Endocrinology; 2018 Jul; 159(7):2670-2675. PubMed ID: 29788220
[TBL] [Abstract][Full Text] [Related]
23. Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.
McKillop AM; Stevenson CL; Moran BM; Abdel-Wahab YHA; Flatt PR
Peptides; 2018 Feb; 100():165-172. PubMed ID: 29412816
[TBL] [Abstract][Full Text] [Related]
24. Lipidomic profiling reveals early-stage metabolic dysfunction in overweight or obese humans.
Mousa A; Naderpoor N; Mellett N; Wilson K; Plebanski M; Meikle PJ; de Courten B
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):335-343. PubMed ID: 30586632
[TBL] [Abstract][Full Text] [Related]
25. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2.
Gao H; Guo Y; Yan Q; Yang W; Li R; Lin S; Bai X; Liu C; Chen D; Cao H; Xiao G
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292295
[TBL] [Abstract][Full Text] [Related]
26. Connecting lipid droplet biology and the metabolic syndrome.
Le Lay S; Dugail I
Prog Lipid Res; 2009; 48(3-4):191-5. PubMed ID: 19303902
[TBL] [Abstract][Full Text] [Related]
27. Macrophage CD40 plays a minor role in obesity-induced metabolic dysfunction.
Aarts SABM; Reiche ME; den Toom M; Beckers L; Gijbels MJJ; Gerdes N; de Winther MPJ; Lutgens E
PLoS One; 2018; 13(8):e0202150. PubMed ID: 30096208
[TBL] [Abstract][Full Text] [Related]
28. Genetic Disruption of Protein Kinase STK25 Ameliorates Metabolic Defects in a Diet-Induced Type 2 Diabetes Model.
Amrutkar M; Cansby E; Chursa U; Nuñez-Durán E; Chanclón B; Ståhlman M; Fridén V; Mannerås-Holm L; Wickman A; Smith U; Bäckhed F; Borén J; Howell BW; Mahlapuu M
Diabetes; 2015 Aug; 64(8):2791-804. PubMed ID: 25845663
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
30. 3-(4-Hydroxy-3-methoxyphenyl)propionic Acid Produced from 4-Hydroxy-3-methoxycinnamic Acid by Gut Microbiota Improves Host Metabolic Condition in Diet-Induced Obese Mice.
Ohue-Kitano R; Taira S; Watanabe K; Masujima Y; Kuboshima T; Miyamoto J; Nishitani Y; Kawakami H; Kuwahara H; Kimura I
Nutrients; 2019 May; 11(5):. PubMed ID: 31075850
[TBL] [Abstract][Full Text] [Related]
31. Genetic ablation of lymphocytes and cytokine signaling in nonobese diabetic mice prevents diet-induced obesity and insulin resistance.
Friedline RH; Ko HJ; Jung DY; Lee Y; Bortell R; Dagdeviren S; Patel PR; Hu X; Inashima K; Kearns C; Tsitsilianos N; Shafiq U; Shultz LD; Lee KW; Greiner DL; Kim JK
FASEB J; 2016 Mar; 30(3):1328-38. PubMed ID: 26644351
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of inflammation-associated genes in the hypothalamus of obesity mouse models.
Park JH; Yoo Y; Han J; Park YJ
Nutr Res; 2019 Oct; 70():40-49. PubMed ID: 30032989
[TBL] [Abstract][Full Text] [Related]
33. A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity.
Vila IK; Park MK; Setijono SR; Yao Y; Kim H; Badin PM; Choi S; Narkar V; Choi SW; Chung J; Moro C; Song SJ; Song MS
JCI Insight; 2019 Jul; 4(13):. PubMed ID: 31292296
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
35. Peroxiredoxin 6 Is a Key Antioxidant Enzyme in Modulating the Link between Glycemic and Lipogenic Metabolism.
Arriga R; Pacifici F; Capuani B; Coppola A; Orlandi A; Scioli MG; Pastore D; Andreadi A; Sbraccia P; Tesauro M; Daniele ND; Sconocchia G; Donadel G; Bellia A; Della-Morte D; Lauro D
Oxid Med Cell Longev; 2019; 2019():9685607. PubMed ID: 31949886
[TBL] [Abstract][Full Text] [Related]
36. Transient receptor potential vanilloid type-1 channel regulates diet-induced obesity, insulin resistance, and leptin resistance.
Lee E; Jung DY; Kim JH; Patel PR; Hu X; Lee Y; Azuma Y; Wang HF; Tsitsilianos N; Shafiq U; Kwon JY; Lee HJ; Lee KW; Kim JK
FASEB J; 2015 Aug; 29(8):3182-92. PubMed ID: 25888600
[TBL] [Abstract][Full Text] [Related]
37. The fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms improves insulin resistance and hepatic lipid accumulation by modulation of liver adenosine monophosphate-activated protein kinase activity and lipogenic gene expression in high-fat diet-fed obese mice.
Saito T; Nishida M; Saito M; Tanabe A; Eitsuka T; Yuan SH; Ikekawa N; Nishida H
Nutr Res; 2016 Oct; 36(10):1090-1097. PubMed ID: 27865350
[TBL] [Abstract][Full Text] [Related]
38. Targeting RalGAPα1 in skeletal muscle to simultaneously improve postprandial glucose and lipid control.
Chen Q; Rong P; Zhu S; Yang X; Ouyang Q; Wang HY; Chen S
Sci Adv; 2019 Apr; 5(4):eaav4116. PubMed ID: 30989113
[TBL] [Abstract][Full Text] [Related]
39. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol ameliorates metabolic disorders and insulin resistance in high-fat diet-fed mice.
Gong L; Guo S; Zou Z
Life Sci; 2020 Feb; 242():117212. PubMed ID: 31884092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
